Yasheng Pharmaceuticals-B (06855.HK) presents five preclinical advances at the 2025 AACR Annual Meeting, demonstrating significant synergistic effects of Nalidik in combination with APG-2575.

Sinnet Financial News APP News, AstraZeneca Pharmaceuticals-B (06855.HK) announced that the company presented five preclinical research results at the 2025 American Association for Cancer Research (AACR) Annual Meeting held in Chicago, USA from April 25, 2025 to April 30, 2025.